Houston-based BrainCheck, developer of a mobile neurocognitive assessment platform, has raised $1.5 million to expand sales, distribution channels, and research opportunities for its product. True Wealth Ventures led the latest round, which, together with the company’s previous raise of $3 million, brings BrainCheck’s total to $4.5 million.
BrainCheck was established in 2014 in a mission to...
There’s plenty of debate about the impact of consumer-level computer or video games on children’s brains. But a new study from the University of California, San Francisco published in PLOS One shows that, in a clinical setting, games that have been developed to function as a medical device may be beneficial to children with certain cognitive impairments.
UCSF and Akili Interactive Labs, which is...
The human brain and the seemingly infinite number of health complications that can befall it are complex. As such, there aren’t universally agreed-upon therapies and treatments for conditions ranging from depression and chronic pain to stroke and Parkinson’s disease. But recent, rapid advances in neuroscience research and digital technology are enabling a new wave of tools to gain traction in...
Boston-based Akili Interactive Labs and Pfizer have released data from a collaborative study showing the use of Akili’s digital, cognitive measurement platform can detect biomarkers of Alzheimer’s disease.
The study, which began in 2014, used Akili’s screening technology called AD Screen. The program targets the brain's interference processing system and then uses an algorithm to deploy a...
Houston-based concussion management system BrainCheck has raised $3 million in seed funding from undisclosed investors to expand its mobile neurocognitive assessment app in two markets. The plan is to deploy the use of BrainCheck to screen for concussions in athletes as well as expand into the senior adult market, where the technology could be adapted to screen for dementia.
BrainCheck, which was...
San Francisco-based Savonix announced the global launch of their cognitive assessment app, Savonix Mobile. The app is accessible on any mobile device, and aims to eliminate the need for pen-and-paper exams to screen for cognitive function. The app was also created to serve as the vehicle for providers, patients and patients to easily incorporate the data into treatment planning and decision-...
Savonix, a new startup working on creating a neurocognitive assessment app, has raised $1.5 million in seed funding. RoundGlass Partners led the round with additional participation from Kickstart Seed Fund, BMNT Capital, and strategic angel investors including Bandel Carano and Ed Glassmeyer.
The San Francisco-based company is focused on creating a brain training and brain testing app that's...
